Mara Gilardi
- Oncology top 5%
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 4
- Bone health and treatments 3
- Peptidase Inhibition and Analysis 3
- Biomedical Engineering top 5%
- 3D Printing in Biomedical Research 10
- Immunology top 10%
- Cell Biology top 5%
- Cellular Mechanics and Interactions 3
- Cancer Research top 10%
-
- Muscle Physiology and Disorders 3
- Protein Degradation and Inhibitors 3
- Co-authors
- Matteo MorettiSimone BersiniRoger D. KammGabriele DubiniJessie S. JeonJoseph L. CharestDaniel P. HollernBrad H. Nelson
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Communications (2 papers)Nature reviews. Cancer (1 paper)
- Partner nations
- United StatesItalySwitzerland
In The Last Decade
Mara Gilardi
31 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 799
- Biomedical Engineering 838
- Immunology 331
- Cell Biology 215
- Cancer Research 196
Countries citing papers authored by Mara Gilardi
This map shows the geographic impact of Mara Gilardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Gilardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Gilardi more than expected).
Fields of papers citing papers by Mara Gilardi
This network shows the impact of papers produced by Mara Gilardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Gilardi. The network helps show where Mara Gilardi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mara Gilardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2023 | 75 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 34 | |
| 5 | Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunitiesbreakdown → | 2022 | 304 |
| 6 | 2021 | 18 | |
| 7 | 2021 | 38 | |
| 8 | 2021 | 51 | |
| 9 | 2020 | 78 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 29 | |
| 13 | 2019 | 54 | |
| 14 | 2019 | 119 | |
| 15 | 2018 | 36 | |
| 16 | 2018 | 54 | |
| 17 | 2017 | 44 | |
| 18 | 2016 | 6 | |
| 19 | 2015 | 81 | |
| 20 | Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasationbreakdown → | 2014 | 597 |
About Mara Gilardi
Mara Gilardi is a scholar working on Oncology, Cell Biology and Biomedical Engineering, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (10 papers), Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (4 papers), Bone health and treatments (3 papers), Muscle Physiology and Disorders (3 papers), Protein Degradation and Inhibitors (3 papers), Cellular Mechanics and Interactions (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (799 citations), Biomedical Engineering (838 citations) and Immunology (331 citations). Mara Gilardi has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Matteo Moretti, Simone Bersini, Roger D. Kamm, Gabriele Dubini, Jessie S. Jeon, Joseph L. Charest, Daniel P. Hollern, Brad H. Nelson, Céline M. Laumont and Allyson C. Banville. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.